Item 16. Form 10-K Summary

None

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	ZIMMER BIOMET HOLDINGS, INC.

	By:	/s/ Bryan Hanson
Dated: February 24, 2023		Bryan Hanson
		Chairman, President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


SIGNATURE	TITLE	DATE
/s/ Bryan Hanson	Chairman, President and Chief Executive Officer	February 24, 2023
Bryan Hanson	(Principal Executive Officer)

/s/ Suketu Upadhyay	Executive Vice President and Chief Financial Officer	February 24, 2023
Suketu Upadhyay	(Principal Financial Officer)

/s/ Paul Stellato	Vice President, Controller and Chief Accounting	February 24, 2023
Paul Stellato	Officer (Principal Accounting Officer)

/s/ Christopher Begley	Director	February 24, 2023
Christopher Begley

/s/ Betsy Bernard	Director	February 24, 2023
Betsy Bernard

/s/ Michael Farrell	Director	February 24, 2023
Michael Farrell

/s/ Robert Hagemann	Director	February 24, 2023
Robert Hagemann

/s/ Arthur Higgins	Director	February 24, 2023
Arthur Higgins

/s/ Maria Teresa Hilado	Director	February 24, 2023
Maria Teresa Hilado

/s/ Syed Jafry	Director	February 24, 2023
Syed Jafry

/s/ Sreelakshmi Kolli	Director	February 24, 2023
Sreelakshmi Kolli

/s/ Michael Michelson	Director	February 24, 2023
Michael Michelson

Previous: Item 15. Exhibits and Financial Statement Schedules